Form 4: Saul Centers Director John E. Chapoton Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Director John E. Chapoton reports acquisition of phantom stock and adjustments to holdings in Saul Centers, Inc.
Summary
- On October 1, 2024, Director John E. Chapoton reported changes in beneficial ownership of Saul Centers, Inc. securities.
- The report details the acquisition of 387.274 phantom stock units under the Issuer's Deferred Compensation Plan for Directors.
- These phantom shares were acquired at a price of $41.96 per share.
- Chapoton's total holdings include 9,466.078 shares of common stock and 25,246.022 phantom stock units.
- The report also lists multiple director stock options with varying exercise prices and expiration dates.
Sentiment
Score: 6
Explanation: The sentiment is neutral as it reflects routine insider transactions. The acquisition of phantom stock can be seen as a positive sign, but it's not a major event.
Positives
- The acquisition of phantom stock aligns the director's interests with the long-term performance of the company.
- The director's continued holding of common stock and stock options demonstrates confidence in the company's future prospects.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The report provides transparency to shareholders regarding insider transactions.
- The acquisition of phantom stock aligns the director's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/08/2015 | Date of Director Stock Option grant with an exercise price of $51.07 and expiration date of 05/08/2025 |
| 05/06/2016 | Date of Director Stock Option grant with an exercise price of $57.74 and expiration date of 05/06/2026 |
| 05/05/2017 | Date of Director Stock Option grant with an exercise price of $59.41 and expiration date of 05/05/2027 |
| 05/11/2018 | Date of Director Stock Option grant with an exercise price of $49.46 and expiration date of 05/11/2028 |
| 05/03/2019 | Date of Director Stock Option grant with an exercise price of $55.71 and expiration date of 05/03/2029 |
| 04/24/2020 | Date of Director Stock Option grant with an exercise price of $50 and expiration date of 04/24/2030 |
| 05/07/2021 | Date of Director Stock Option grant with an exercise price of $43.89 and expiration date of 05/07/2031 |
| 05/13/2022 | Date of Director Stock Option grant with an exercise price of $47.9 and expiration date of 05/13/2032 |
| 05/12/2023 | Date of Director Stock Option grant with an exercise price of $33.79 and expiration date of 05/12/2033 |
| 05/17/2024 | Effective date of the amended and restated Deferred Compensation Plan for Directors. |
| 07/31/2024 | Award date of 370.839 shares as dividend reinvestments on phantom stock. |
| 10/01/2024 | Date of transaction: Acquisition of 387.274 phantom stock units. |
| 10/02/2024 | Date of report filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.